REG - Accrol Group Hldgs - Result of AGM

Accrol groupAnnouncement

22/10/2019 11:35

RNS Number : 7213Q
Accrol Group Holdings PLC
22 October 2019
 


22 October 2019
 
Accrol Group Holdings plc
("Accrol", the "Company" or the "Group")
AIM: ACRL



Result of 2019 Annual General Meeting
 
Accrol, the leading independent tissue converter in the UK, announces that all of the resolutions set out in the Notice of AGM were passed by the requisite majority at the Company's AGM, held earlier today.
 
Details of the proxy votes received by the Company are as follows:
 



Resolution


For


Against


Total


Withheld








No. of votes


%


No. of votes


%


No. of votes


%


No. of votes




1.     To receive the Annual Report and Accounts


122,707,536


99.97


28,611


0.02


122,736,147


100.00
 


0




2.     To elect Simon Allport


118,764,933


96.82


3,889,105


3.17


122,654,038


100.00
 


82,109




3.     To appoint BDO as auditor


122,219,373


99.64


428,680


0.35


122,648,053


100.00
 


88,094




4.     To approve the directors' remuneration report


73,488,398


69.77


31,823,226


30.22


105,311,624


100.00
 


17,424,523




5.     To authorise the Directors to allot relevant securities


118,751,224


99.90


116,058


0.1


118,867,282


100.00
 


3,860,494




6.     To authorise the directors to allot equity securities for cash without making a pre-      emptive offer to shareholders*


122,605,671


99.91


116,058


0.09


122,721,729


100.00
 


6,047



 
*Special resolution
 
Notes:
 



1.


Proxy appointments which gave discretion to the Chairman of the AGM have been included in the "For" total for the appropriate resolution.




2.


Votes "For" and "Against" any resolution are expressed as a percentage of votes validly cast for that resolution.




3.


A "Vote withheld" is not a vote in law and is not counted in the calculation of the percentage of shares voted "For" or "Against".




4.


The number of shares in issue on 22 October 2019 was 195,246,536 with no shares in treasury. 




5.


The full text of the resolutions passed at the AGM can be found in the Notice of Annual General Meeting which is available on the Company's website at www.accrol.com.



 
In compliance with the QCA Code, the Board notes the percentage of votes cast against Resolution 4 to approve the directors' remuneration report. Shareholders with significant holdings in the Company were consulted ahead of the vote and the Board remains open to further discussions.
 
Enquiries:
 



For further information, please contact:


















Accrol Group Holdings plc








Dan Wright, Executive Chairman


Tel: +44 (0) 1254 278 844




Gareth Jenkins, Chief Executive Officer


















Zeus Capital Limited (Nominated Adviser & Broker) 








Dan Bate / Andrew Jones  


Tel: +44 (0) 161 831 1512




Dominic King / John Goold


Tel: +44 (0) 203 829 5000














Belvedere Communications Limited








Cat Valentine (cvalentine@belvederepr.com)


Tel: +44 (0) 7715 769 078




Keeley Clarke (kclarke@belvederepr.com)


Tel: +44 (0) 7967 816 525




Llew Angus (langus@belvederpr.com)


Tel:  +44 (0) 7407 023 147



 
Notes to Editors
 
New Group website: www.accrol.com
 
Accrol Group Holdings plc is a leading tissue converter and supplier of toilet rolls, kitchen rolls and facial tissues, as well as other tissue products, to major discounters and grocery retailers throughout the UK. 
 
Our vision is to deliver the best possible value to the UK consumer on essential everyday tissue products. We are shaking up the traditional tissue brands by delivering the quality the consumer demands for the price they want to pay.
 
The business operates from four sites in Lancashire:
 
•              A manufacturing, storage and distribution facility in Blackburn;
•              A storage and administrative centre in Blackburn;
•              A facial tissue plant, also in Blackburn; and
•              A manufacturing, storage and distribution facility in Leyland.
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGUUURRKWARUAA